FDA Grants 510(k) Clearance For HeartSciences’ MyoVista wavECGTM Device As 12-Lead Resting Electrocardiograph

HeartSciences Inc. (NASDAQ: HSCS) has received 510(k) clearance from the FDA for its MyoVista wavECG device, allowing it to function as a 12-lead resting electrocardiograph for both adult and pediatric patients. This clearance facilitates the acquisition and interpretation of ECG signals, though it does not include an AI-ECG algorithm. The company has separated its FDA submissions for the device and the AI-ECG algorithm and currently has no plans or timeline for commercialization without the algorithm.